EP-102 (Epics therapeutics)

N/A

Report date: 2025/09/11 20:00:08
NME

Base Information

Drug NameEP-102 (Epics therapeutics)
Drug Alias NameEP-102 (Epics therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionN6-adenosine-methyltransferase catalytic subunit inhibitors
TargetsN6-adenosine-methyltransferase catalytic subunit
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumNetherlands +[4] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesEPICS Therapeutics SA
China Registration ClassN/A

Develop Information

Active CompaniesEPICS Therapeutics SA
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A